Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025)

Basel Medical (BMGL) posted Long-Term Deferred Tax of $47875.0 for Q4 2025, up 30.17% sequentially from $36779.8 in Q2 2025, and down 37.83% YoY from $77005.0 in Q4 2024.

Basel Medical (BMGL) Long-Term Deferred Tax (2024 - 2025) Analysis & Trends

Basel Medical (BMGL) has 2 years of Long-Term Deferred Tax data on file, last reported at $47875.0 in Q4 2025.

  • Quarterly Long-Term Deferred Tax fell 37.83% year-over-year to $47875.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $47875.0 (down 37.83% YoY) and the FY2025 annual result came in at $36134.4, down 36.51% from the prior year.
  • Long-Term Deferred Tax rose to $47875.0 in Q4 2025 per BMGL's latest filing, from $36779.8 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $77005.0 in Q4 2024, with the low at $36779.8 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Basel Medical 133.19 Mn 130.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 47,875.00
Jun 30, 2025 36,779.79
Dec 31, 2024 77,005.00
Jun 30, 2024 56,916.48